Document 0001 DOCN M9460001 TI Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNAase I footprinting study. DT 9408 AU Feriotto G; Mischiati C; Gambari R; Biochemistry Institute, Ferrara University, Italy. SO Biochem J. 1994 Apr 15;299 ( Pt 2):451-8. Unique Identifier : AIDSLINE MED/94226609 AB Pharmacological modulation of the interaction between transcription factors and target DNA sequences of cellular and viral genes could have important effects in the experimental therapy of a large variety of human pathologies. For instance, alteration of the DNA/protein interaction might be among the molecular mechanisms of action of DNA-binding drugs, leading to an inhibition of the expression of genes involved in the control of in vitro and in vivo growth of neoplastic cells and virus DNA replication. Natural oligopeptides, such as distamycin, are powerful inhibitors of the interaction between nuclear factors and target DNA sequences and, therefore, have been proposed as compounds retaining antibiotic, antineoplastic and antiviral properties. In this study we performed DNAase I footprinting analysis using a PCR product mimicking a region of the long terminal repeat (LTR) of the human immunodeficiency type 1 (HIV-1) retrovirus. The data obtained suggest that distamycin binds to different regions of the HIV-1 LTR depending on the DNA sequence. Electrophoretic mobility shift assays using both crude nuclear extracts from the Jurkat T-lymphoid cell line and the recombinant proteins transcription factor IID and Sp1 suggest that distamycin differentially inhibits the interaction of these two proteins with their specific DNA target sequences, in good agreement with the results obtained by DNAase I footprinting analysis. DE Base Sequence Binding Sites Consensus Sequence Deoxyribonuclease I Distamycins/*METABOLISM DNA, Viral/*METABOLISM Genes, Viral Genome, Viral Human *HIV Long Terminal Repeat HIV-1/*GENETICS/METABOLISM Molecular Sequence Data Support, Non-U.S. Gov't JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).